Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.

[1]  E. Braunwald,et al.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. , 1997, Circulation.

[2]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[3]  T. Henry,et al.  Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. , 1996, American journal of clinical pathology.

[4]  P. Steg,et al.  A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. , 1995, Circulation.

[5]  T. Henry,et al.  Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Mccabe,et al.  Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? , 1995, American journal of clinical pathology.

[7]  E. Topol,et al.  Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. , 1995, Clinical chemistry.

[8]  K. Daly,et al.  Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. , 1995, British heart journal.

[9]  C. Cannon,et al.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.

[10]  E. Topol,et al.  Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.

[11]  J. Ishii,et al.  Early detection of successful coronary reperfusion based on serum myoglobin concentration: comparison with serum creatine kinase isoenzyme MB activity. , 1994, American heart journal.

[12]  A. Jaffe,et al.  Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. , 1994, Clinical chemistry.

[13]  M. Miyata,et al.  Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[14]  C. Bode,et al.  Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. , 1994, British heart journal.

[15]  E. Braunwald,et al.  GUSTO, TIMI and the case for rapid reperfusion. , 1994, Acta cardiologica.

[16]  E. Braunwald.  The open-artery theory is alive and well--again. , 1993, The New England journal of medicine.

[17]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[18]  R. Califf,et al.  Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. , 1993, American heart journal.

[19]  Jack H. Ladenson,et al.  Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.

[20]  L. Becker,et al.  TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study , 1993, Circulation.

[21]  S. Hohnloser,et al.  Analysis of Creatine Kinase, CK‐MB, Myoglobin, and Troponin T Time‐Activit Curves for Early Assessment of Coronary Artery Reperfusion After Intravenous Thrombolysis , 1993, Circulation.

[22]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[23]  J. Ladenson,et al.  Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. , 1992, Clinical chemistry.

[24]  E. Topol,et al.  Thrombolytic therapy: adjuvant mechanical intervention for acute myocardial infarction. , 1992, The American journal of cardiology.

[25]  J. Ladenson,et al.  Development and application of monoclonal antibodies to human cardiac myoglobin in a rapid fluorescence immunoassay. , 1991, Clinical chemistry.

[26]  S. Hohnloser,et al.  Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. , 1991, Journal of the American College of Cardiology.

[27]  A. Remppis,et al.  Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. , 1991, The American journal of cardiology.

[28]  P. Gurbel,et al.  Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty. , 1990, The American journal of cardiology.

[29]  T. Takala,et al.  Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. , 1990, Clinical chemistry.

[30]  K. Bailey,et al.  Emergency "rescue" percutaneous transluminal coronary angioplasty after failed thrombolysis with streptokinase. Early and late results. , 1990, Circulation.

[31]  J. Chapelle,et al.  Automated quantification of creatine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer. , 1990, Clinical chemistry.

[32]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[33]  F. Klocke,et al.  Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. , 1988, Circulation.

[34]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[35]  B. Lewis,et al.  Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. , 1988, The American journal of cardiology.

[36]  H. Katus,et al.  Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. , 1988, European Heart Journal.

[37]  R. Califf,et al.  Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. , 1988, Annals of internal medicine.

[38]  H. Gold,et al.  Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. , 1988, Journal of the American College of Cardiology.

[39]  R. Roberts,et al.  Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man. , 1987, Circulation.

[40]  E. Topol,et al.  Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.

[41]  M. Krucoff,et al.  Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. , 1986, The American journal of cardiology.

[42]  J. Ladenson,et al.  Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. , 1986, Clinical chemistry.

[43]  A. R. Zaki Masud,et al.  Patterns of myoglobin release after reperfusion of injured myocardium. , 1985, Circulation.

[44]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[45]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[46]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .